286 related articles for article (PubMed ID: 22402492)
21. Recognition of UbcH5c and the nucleosome by the Bmi1/Ring1b ubiquitin ligase complex.
Bentley ML; Corn JE; Dong KC; Phung Q; Cheung TK; Cochran AG
EMBO J; 2011 Jul; 30(16):3285-97. PubMed ID: 21772249
[TBL] [Abstract][Full Text] [Related]
22. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.
Morris JR; Boutell C; Keppler M; Densham R; Weekes D; Alamshah A; Butler L; Galanty Y; Pangon L; Kiuchi T; Ng T; Solomon E
Nature; 2009 Dec; 462(7275):886-90. PubMed ID: 20016594
[TBL] [Abstract][Full Text] [Related]
23. Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b.
Buchwald G; van der Stoop P; Weichenrieder O; Perrakis A; van Lohuizen M; Sixma TK
EMBO J; 2006 Jun; 25(11):2465-74. PubMed ID: 16710298
[TBL] [Abstract][Full Text] [Related]
24. SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy.
Lin FM; Kumar S; Ren J; Karami S; Bahnassy S; Li Y; Zheng X; Wang J; Bawa-Khalfe T
Oncotarget; 2016 May; 7(21):30336-49. PubMed ID: 27107417
[TBL] [Abstract][Full Text] [Related]
25. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
[TBL] [Abstract][Full Text] [Related]
26. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
[TBL] [Abstract][Full Text] [Related]
27. SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.
Andrade D; Velinder M; Singer J; Maese L; Bareyan D; Nguyen H; Chandrasekharan MB; Lucente H; McClellan D; Jones D; Sharma S; Liu F; Engel ME
Mol Cell Biol; 2016 May; 36(10):1438-50. PubMed ID: 26951200
[TBL] [Abstract][Full Text] [Related]
28. An anticlastogenic function for the Polycomb Group gene Bmi1.
Chagraoui J; Hébert J; Girard S; Sauvageau G
Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5284-9. PubMed ID: 21402923
[TBL] [Abstract][Full Text] [Related]
29. Activation of the SUMO modification system is required for the accumulation of RAD51 at sites of DNA damage.
Shima H; Suzuki H; Sun J; Kono K; Shi L; Kinomura A; Horikoshi Y; Ikura T; Ikura M; Kanaar R; Igarashi K; Saitoh H; Kurumizaka H; Tashiro S
J Cell Sci; 2013 Nov; 126(Pt 22):5284-92. PubMed ID: 24046452
[TBL] [Abstract][Full Text] [Related]
30. CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells.
Ren L; Li Z; Zhou Y; Zhang J; Zhao Z; Wu Z; Zhao Y; Ju Y; Pang X; Sun X; Wang W; Zhang Y
Mol Oncol; 2023 Dec; 17(12):2694-2708. PubMed ID: 37691307
[TBL] [Abstract][Full Text] [Related]
31. RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.
Satijn DP; Otte AP
Mol Cell Biol; 1999 Jan; 19(1):57-68. PubMed ID: 9858531
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
33. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
[TBL] [Abstract][Full Text] [Related]
34. Cutting Edge: Polycomb Repressive Complex 1 Subunit Cbx4 Positively Regulates Effector Responses in CD8 T Cells.
Melo GA; Xu T; Calôba C; Schutte A; Passos TO; Neto MAN; Brum G; Oliveira-Vieira B; Higa L; Monteiro FLL; Berbert L; Gonçalves ANA; Tanuri A; Viola JPB; Werneck MBF; Nakaya HI; Pipkin ME; Martinez GJ; Pereira RM
J Immunol; 2023 Sep; 211(5):721-726. PubMed ID: 37486206
[TBL] [Abstract][Full Text] [Related]
35. Multisite SUMOylation restrains DNA polymerase η interactions with DNA damage sites.
Guérillon C; Smedegaard S; Hendriks IA; Nielsen ML; Mailand N
J Biol Chem; 2020 Jun; 295(25):8350-8362. PubMed ID: 32350109
[TBL] [Abstract][Full Text] [Related]
36. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
[TBL] [Abstract][Full Text] [Related]
37. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing.
Negishi M; Saraya A; Miyagi S; Nagao K; Inagaki Y; Nishikawa M; Tajima S; Koseki H; Tsuda H; Takasaki Y; Nakauchi H; Iwama A
Biochem Biophys Res Commun; 2007 Feb; 353(4):992-8. PubMed ID: 17214966
[TBL] [Abstract][Full Text] [Related]
38. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.
Wu CS; Zou L
J Biol Chem; 2016 Jan; 291(1):279-90. PubMed ID: 26565033
[TBL] [Abstract][Full Text] [Related]
39. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1.
Voncken JW; Niessen H; Neufeld B; Rennefahrt U; Dahlmans V; Kubben N; Holzer B; Ludwig S; Rapp UR
J Biol Chem; 2005 Feb; 280(7):5178-87. PubMed ID: 15563468
[TBL] [Abstract][Full Text] [Related]
40. RNF4 is required for DNA double-strand break repair in vivo.
Vyas R; Kumar R; Clermont F; Helfricht A; Kalev P; Sotiropoulou P; Hendriks IA; Radaelli E; Hochepied T; Blanpain C; Sablina A; van Attikum H; Olsen JV; Jochemsen AG; Vertegaal AC; Marine JC
Cell Death Differ; 2013 Mar; 20(3):490-502. PubMed ID: 23197296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
